Effects of intravenous hyoscine butylbromide-oxytocin or oxytocin on the duration of labor in term pregnancies;Efectos del butil bromuro de hioscina-oxitocina u oxitocina intravenosos en la duración del parto de embarazos a término

Progresos de Obstetricia y Ginecologia

Volumn 53, Issue 12, 2010, Pages 502-506

  De Nobrega Correa, Helen ^a   Guerra Velásquez, Mery ^a   Reyna Villasmil, Eduardo ^a   Mejia Montilla, Jorly ^a   Reyna Villasmil, Nadia ^a   Torres Cepeda, Duly ^a   Santos Bolívar, Joel ^a   Perozo Romero, Juan ^a  

^a HOSPITAL CENTRAL DR URQUINAONA   (Venezuela)

Author keywords

Hyoscine; Labor; Oxytocin; Term pregnancy

Indexed keywords

OXYTOCIN; SCOPOLAMINE BUTYL BROMIDE;

ABSENCE OF SIDE EFFECTS; ADULT; ADVERSE OUTCOME; APGAR SCORE; ARTICLE; CLINICAL ARTICLE; DELIVERY; DRUG EFFECT; FEMALE; HUMAN; LABOR; LABOR MANAGEMENT; PREGNANCY; PREGNANT WOMAN; TREATMENT OUTCOME; UTERINE CERVIX DILATATION;

EID: 78649819171     PISSN: 03045013     EISSN: 15781453     Source Type: Journal    
DOI: 10.1016/j.pog.2010.08.004     Document Type: Article

References (15)

1. Samuels L., Christie L., Roberts-Gittens B., Fletcher H., Frederick J. The effect of hyoscine butylbromide on the first stage of labour in term pregnancies. BJOG. 2007, 114:1542-1546.
2. Foley M., Alarab M., Daly L., Keane D., Rath A., O'herlihy C. The continuing effectiveness of active management of first labor, despite a doubling in overall nulliparous cesarean delivery. Am J Obstet Gynecol. 2004, 191:891-895.
3. Bio E., Bittar R., Zugaib M. Influence of maternal morbility on duration of the active phase of labor. Rev Bras Ginecol Obstet. 2006, 28:671-679.
4. Omole-Ohonsi A., Muhammad Z., Iliyasu Z. Value of partogram in vaginal birth after caesarean section. J Obstet Gynaecol. 2007, 27:264-266.
5. Hotwani J., Ainapure S. Hyoscine Butylbromide suppositories. Indian Medical Gaz. 2000, 1:217-219.
6. Chaillet N., Dumont A. Evidence-based strategies for reducing cesarean section rates: a meta-analysis. Birth. 2007, 34:53-64.
7. Baracho H., Kamat J., Kunhalekar, Jarob L. Buscopan in acceleration of labor. J Obstet Gynecol Ind. 1982, 34:509-512.
8. Tewari K., Jabeen R., Sabzposh N., Rabbani T. Comparison of hyoscine-butylbromide and valethamate bromide in shortening the duration of labour. Ind Med Gaz. 2003, 137:15-19.
9. Sirohiwal D., Dahiya K., De M. Efficacy of hyoscine-N-butyl bromide (Buscopan) suppositories as a cervical spasmolytic agent in labour. Aust N Z J Obstet Gynaecol. 2005, 45:128-129.
10. Samal S., Gupta U., Wable M. Buscopan (Hyoscine-NButylbromide) in acceleration of labour. Ind Med Gaz. 1998, 132:8-10.
11. Sharma J., Pundir P., Kumar A., Murthy N. Drotaverine hydrochloride vs. valethamate bromide in acceleration of labor. Int J Gynaecol Obstet. 2001, 74:255-260.
12. Manpreet T., Gouramba S., Jyothi K., Biradar V. A comparative study of Hyoscine butylbromide versus drotaverine hydrochloride in first stage of labor. J Obstet Gynecol India. 2008, 58:230-234.
13. Bauer M., Mazza E., Nava A., Zeck W., Eder M., Bajka M., et al. In vivo characterization of the mechanics of human uterine cervices. Ann N Y Acad Sci. 2007, 1101:186-202.
14. Blasko G. Pharmacology, mechanism of action and clinical significance of a convenient antispasmodic agent drotaverine. J Am Med Assoc Ind Physicians Update. 1998, 16:63-69.
15. Singh K., Jain P., Goel N., Saxena A. Drotaverine hydrochloride for augmentation of labor. Int J Gynaecol Obstet. 2004, 84:17-22.